Table 1_Situs inversus totalis and lung cancer: a case report of surgical resection after

A 2026 case report by Wenhao Wang details a patient with situs inversus totalis and advanced lung squamous cell carcinoma. The report describes the patient's diagnosis, staging as cT3N2M0 (stage IIIB), treatment with three cycles of pembrolizumab, cisplatin, and paclitaxel, and subsequent surgical resection. It includes specific tumor measurements, PET-CT SUVmax values, and pathological staging results before and after therapy.

Use Cases

• Analyzing treatment response metrics based on pre- and post-therapy tumor size and SUVmax values described in the report.
• Studying surgical feasibility in complex cases based on the multidisciplinary team discussion and VATS lobectomy outcome detailed.
• Researching pathological complete response rates in lymph nodes based on the final pathology findings mentioned.
• Investigating clinical staging protocols based on the detailed cT3N2M0 to ypT1cN0M0 staging progression described.

Strengths

• Provides specific quantitative clinical data, including tumor dimensions (6.5 × 5.0 cm, 1.9×1.7 cm) and PET-CT SUVmax values (13.7, 8.9).
• Includes detailed treatment regimen information (pembrolizumab 200 mg, cisplatin 60 mg, paclitaxel 270 mg for three cycles).
• Documents a complete clinical timeline from diagnosis through neoadjuvant therapy, surgery, and adjuvant treatment.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Wenhao Wang via figshare

Collection Method

Single clinical case report.

Time Range

Case report published in 2026.

Freshness

Last updated 2026-04-20 04:11:41; freshness should be verified.

Geography

Geography of the patient and treating institution is not specified.